Literature DB >> 19137636

Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium.

G Pedersen1, T Saermark, T Kirkegaard, J Brynskov.   

Abstract

Matrix metalloproteinases (MMPs) have been implicated in tissue damage associated with inflammatory bowel disease (IBD).As the role of the intestinal epithelium in this process is unknown, we determined MMP expression and enzyme activity in human colonic epithelial cells (CEC). MMP mRNA expression was assessed by reverse transcription-polymerase chain reaction in HT-29 and DLD-1 cells and in CEC isolated from biopsies from IBD and control patients. Total MMP activity in the cells was measured by a functional assay, based on degradation of a fluorescent synthetic peptide containing the specific bond for MMP cleavage. HT-29 and DLD-1 expressed several MMPs and levels of MMP-3, -10 and -13 mRNA expression were increased significantly by tumour necrosis factor (TNF)-alpha exposure. Transcripts of MMP-1, -3, -7, -9, -10 and -12 were detected in CECs and all, except MMP12, at significantly increased levels in cells from inflamed IBD mucosa. MMP-2 and -8 mRNA were expressed inconsistently and MMP-11, -13 and -14 mRNA undetectable. Proteolytic MMP activity was detected in CEC supernatants and the level was increased significantly in inflamed IBD epithelium. The enzyme activity was inhibited strongly by a specific MMP inhibitor (GM 6001). A significant TNF-alpha-mediated increase in MMP enzyme activity was also detected in HT-29 cells in vitro. In conclusion, the expression of several MMPs as well as the level of functional MMPactivity is increased in CEC from patients with active IBD. The results suggest that MMPs released by the intestinal epithelium may be involved in the pathogenesis of IBD by promoting local mucosal damage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19137636      PMCID: PMC2675257          DOI: 10.1111/j.1365-2249.2008.03836.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  44 in total

1.  Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis.

Authors:  A Stallmach; C C Chan; K W Ecker; G Feifel; H Herbst; D Schuppan; M Zeitz
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

2.  Comparative studies of the colonic in situ expression of intercellular adhesion molecules (ICAM-1, -2, and -3), beta2 integrins (LFA-1, Mac-1, and p150,95), and PECAM-1 in ulcerative colitis and Crohn's disease.

Authors:  B Vainer; O H Nielsen; T Horn
Journal:  Am J Surg Pathol       Date:  2000-08       Impact factor: 6.394

3.  The role of up-regulated serine proteases and matrix metalloproteinases in the pathogenesis of a murine model of colitis.

Authors:  J F Tarlton; C V Whiting; D Tunmore; S Bregenholt; J Reimann; M H Claesson; P W Bland
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

4.  Cultures of human colonic epithelial cells isolated from endoscopical biopsies from patients with inflammatory bowel disease. Effect of IFNgamma, TNFalpha and IL-1beta on viability, butyrate oxidation and IL-8 secretion.

Authors:  G Pedersen; T Saermark; K Bendtzen; J Brynskov
Journal:  Autoimmunity       Date:  2000-12       Impact factor: 2.815

5.  A simple method to establish short-term cultures of normal human colonic epithelial cells from endoscopic biopsy specimens. Comparison of isolation methods, assessment of viability and metabolic activity.

Authors:  G Pedersen; T Saermark; B Giese; A Hansen; B Drag; J Brynskov
Journal:  Scand J Gastroenterol       Date:  2000-07       Impact factor: 2.423

6.  Stromelysin-2 is upregulated during normal wound repair and is induced by cytokines.

Authors:  O Rechardt; O Elomaa; M Vaalamo; K Pääkkönen; T Jahkola; J Höök-Nikanne; R M Hembry; L Häkkinen; J Kere; U Saarialho-Kere
Journal:  J Invest Dermatol       Date:  2000-11       Impact factor: 8.551

7.  Matrix metalloproteinases: biologic activity and clinical implications.

Authors:  A R Nelson; B Fingleton; M L Rothenberg; L M Matrisian
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

8.  Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease.

Authors:  R B Heuschkel; T T MacDonald; G Monteleone; M Bajaj-Elliott; J A Smith; S L Pender
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

9.  Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.

Authors:  B von Lampe; B Barthel; S E Coupland; E O Riecken; S Rosewicz
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

10.  Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis.

Authors:  Ying-De Wang; Jing-Wei Mao
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

View more
  24 in total

Review 1.  New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease.

Authors:  Darla R Shores; David G Binion; Bruce A Freeman; Paul R S Baker
Journal:  Inflamm Bowel Dis       Date:  2010-12-03       Impact factor: 5.325

2.  Association between TNF-alpha and Entamoeba histolytica diarrhea.

Authors:  Kristine M Peterson; Jianfen Shu; Priya Duggal; Rashidul Haque; Dinesh Mondal; William A Petri
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

3.  A Role for CXCR3 Ligands as Biomarkers of Post-Operative Crohn's Disease Recurrence.

Authors:  Margaret Walshe; Shadi Nayeri; Jiayi Ji; Cristian Hernandez-Rocha; Ksenija Sabic; Liangyuan Hu; Mamta Giri; Shikha Nayar; Steven Brant; Dermot P B McGovern; John D Rioux; Richard H Duerr; Judy H Cho; Phil L Schumm; Mark Lazarev; Mark S Silverberg
Journal:  J Crohns Colitis       Date:  2022-07-14       Impact factor: 10.020

Review 4.  Digestive Inflammation: Role of Proteolytic Dysregulation.

Authors:  Vincent Mariaule; Aicha Kriaa; Souha Soussou; Soufien Rhimi; Houda Boudaya; Juan Hernandez; Emmanuelle Maguin; Adam Lesner; Moez Rhimi
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

5.  Disruption of epithelial barrier by quorum-sensing N-3-(oxododecanoyl)-homoserine lactone is mediated by matrix metalloproteinases.

Authors:  Sung Yong Eum; Dima Jaraki; Luc Bertrand; Ibolya E András; Michal Toborek
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-17       Impact factor: 4.052

6.  Chymase-mediated intestinal epithelial permeability is regulated by a protease-activating receptor/matrix metalloproteinase-2-dependent mechanism.

Authors:  Katherine R Groschwitz; David Wu; Heather Osterfeld; Richard Ahrens; Simon P Hogan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-01-10       Impact factor: 4.052

Review 7.  Matrix metalloproteinases in inflammatory bowel disease: an update.

Authors:  Shane O'Sullivan; John F Gilmer; Carlos Medina
Journal:  Mediators Inflamm       Date:  2015-04-08       Impact factor: 4.711

8.  Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer.

Authors:  Derek C Marshall; Susan K Lyman; Scott McCauley; Maria Kovalenko; Rhyannon Spangler; Chian Liu; Michael Lee; Christopher O'Sullivan; Vivian Barry-Hamilton; Haben Ghermazien; Amanda Mikels-Vigdal; Carlos A Garcia; Brett Jorgensen; Arleene C Velayo; Ruth Wang; Joanne I Adamkewicz; Victoria Smith
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

Review 9.  ECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammation.

Authors:  Elee Shimshoni; Doron Yablecovitch; Liran Baram; Iris Dotan; Irit Sagi
Journal:  Gut       Date:  2014-11-21       Impact factor: 23.059

10.  Alterations of Dermal Connective Tissue Collagen in Diabetes: Molecular Basis of Aged-Appearing Skin.

Authors:  Angela J Argyropoulos; Patrick Robichaud; Rebecca Mutesi Balimunkwe; Gary J Fisher; Craig Hammerberg; Yan Yan; Taihao Quan
Journal:  PLoS One       Date:  2016-04-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.